News stories about SeaSpine (NASDAQ:SPNE) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. SeaSpine earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.9403879779094 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
A number of analysts recently issued reports on SPNE shares. Zacks Investment Research upgraded SeaSpine from a “hold” rating to a “buy” rating and set a $12.00 price objective on the stock in a research note on Wednesday, November 8th. Ladenburg Thalmann Financial Services started coverage on SeaSpine in a research note on Thursday, December 14th. They set a “buy” rating and a $20.00 price objective on the stock. BTIG Research reiterated a “buy” rating on shares of SeaSpine in a research note on Monday, November 6th. Finally, HC Wainwright reiterated a “buy” rating and set a $15.00 price objective on shares of SeaSpine in a research note on Friday, November 3rd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $17.25.
SeaSpine (NASDAQ SPNE) traded up $0.08 during trading on Friday, reaching $10.22. The company had a trading volume of 7,745 shares, compared to its average volume of 23,571. SeaSpine has a twelve month low of $6.31 and a twelve month high of $13.46. The stock has a market capitalization of $137.25 and a PE ratio of -3.51.
COPYRIGHT VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/01/13/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-seaspine-spne-share-price.html.
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.
Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.